71 results
New CPD activities for GPs
Thanks to your insightful feedback, we have enhanced our three GP online training modules, providing opportunities for reflection, consolidating your learning and using the information in your practice.
News
Posted 18 Feb, 2026
Supporting young patients to quit
The latest National Child Health Poll from The Royal Children’s Hospital asked Australian parents and children aged between 12 and 17 years about their knowledge, attitudes, and behaviours related to nicotine products including cigarettes, vapes and oral nicotine pouches.
News Research
Posted 18 Feb, 2026
New Pharmacist training from PSA
The Pharmaceutical Society of Australia (PSA) has launched a new training module on advancing practice in supply and dispensing of nicotine vaping products.
News
Posted 1 Dec, 2025
For patients with COPD who smoke, it's never too late to quit
A recently published comprehensive analysis revealed important benefits of smoking cessation in Chronic Pulmonary Obstructive Disease (COPD). It is never too late to quit, and smoking cessation care is a matter of priority for all patients with COPD who smoke.
News
Posted 18 Nov, 2025
Quit Centre Quarterly Newsletter - November 2025
Quit Centre Quarterly Newsletter - November 2025
The spring edition of Quit Centre Quarterly is out now and it's full of essential information for primary health professionals.
News Newsletter
Posted 13 Nov, 2025
The importance of smoking and vaping cessation in patients with seasonal asthma
For patients with seasonal (allergic) asthma, smoking and vaping cessation is important. Smoking can worsen respiratory health and trigger symptoms. It's associated with poorer asthma control, reduced lung function, and increased hospitalisations.
News
Posted 21 Oct, 2025
Impact of advice to quit smoking on rating of care
A nationwide survey of adults who visited their GP in the past year assessed whether frequency of advice to quit smoking impacts patient rating of care.
News Research
Posted 21 Oct, 2025
Nicotine replacement therapy aid for the treatment of nicotine vaping dependence
A faster-acting nicotine replacement therapy (NRT) product (mouth spray) has recently been approved by the Therapeutic Goods Administration (TGA) as the first NRT aid for the treatment of tobacco and nicotine vaping dependence by relieving nicotine withdrawal symptoms from smoking and vaping, thereby facilitating cessation in people who smoke and people who vape, who are motivated to quit.
News
Posted 21 Oct, 2025